Sophia Genetics raised €26M in a Series D+ round in Jul 2017. The company is based in Saint-Sulpice, Switzerland. Investors in the round: 360 Capital Partners, Alychlo, Balderton Capital and 1 other. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
